RESUMEN
In genetic diagnostics, the emergence of a so-called "patent thicket" is imminent. Such an overlapping set of patent rights may have restrictive effects on further research and development of diagnostic tests, and the provision of clinical diagnostic services. Currently, two models that may facilitate access to and use of patented genetic inventions are attracting much debate in various national and international fora: patent pools and clearing houses. In this article, we explore the concept of clearing houses. Several types of clearing houses are identified. First, we describe and discuss two types that would provide access to information on the patented inventions: the information clearing house and the technology exchange clearing house. Second, three types of clearing houses are analysed that not only offer access to information but also provide an instrument to facilitate the use of the patented inventions: the open access clearing house, the standardized licences clearing house and the royalty collection clearing house. A royalty collection clearing house for genetic diagnostic testing would be the most comprehensive as it would serve several functions: identifying patents and patent claims essential to diagnostic testing, matching licensees with licensors, developing and supplying standardized licences, collecting royalties, monitoring whether users respect licensing conditions, and providing dispute resolution services such as mediation and arbitration. In this way, it might function as an effective model for users to facilitate access to and use of the patented inventions. However, it remains to be seen whether patent holders with a strong patent portfolio will be convinced by the advantages of the royalty collection clearing house and be willing to participate.
Asunto(s)
Acceso a la Información , Bases de Datos Genéticas , Pruebas Diagnósticas de Rutina , Patentes como Asunto , Humanos , Modelos OrganizacionalesRESUMEN
There is increasing concern that overlapping patents in the field of genetics will create a costly and legally complex situation known as a patent thicket, which, along with the associated issues of accumulating royalty payments, can act as a disincentive for innovation. One potential means of preventing this is for the patent holders to enter into a so-called patent pool, such as those established in the electronics and telecommunications industries. Precedents for these also exist in the field of genetics, notably with the patents pertaining to the SARS genome. In this review, we initially address the patent pool concept in general and its application in genetics. Following this, we will explore patent pools in the diagnostic field in more detail, and examine some existing and novel examples of patent pools in genetics.
Asunto(s)
Técnicas de Laboratorio Clínico , Genética , Patentes como Asunto , Animales , Técnicas de Laboratorio Clínico/economía , Técnicas de Laboratorio Clínico/tendencias , Genética/economía , Genética/legislación & jurisprudencia , Genética/tendencias , Genoma Viral/genética , Humanos , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/genéticaRESUMEN
The genetics community is increasingly concerned that patents might lead to restricted access to research and health care. We explore various measures that are designed to render patented genetic inventions accessible to further use in research, and to diagnosis and/or treatment. They include the often-recited research or experimental-use exemption, conventional one-to-one licensing and compulsory licensing, as well as patent pools and clearing-house mechanisms. The last two alternatives deserve special attention in the area of human genetics.
Asunto(s)
Acceso a la Información , Genética Médica , Concesión de Licencias , Modelos Económicos , Patentes como Asunto , Acceso a la Información/legislación & jurisprudencia , Genética Médica/economía , Genética Médica/legislación & jurisprudencia , Genética Médica/tendencias , Concesión de Licencias/economía , Concesión de Licencias/legislación & jurisprudencia , Concesión de Licencias/tendencias , Patentes como Asunto/legislación & jurisprudencia , Investigación/economía , Investigación/legislación & jurisprudencia , Investigación/tendenciasRESUMEN
In the ongoing debate concerning DNA patents, there is a need for empirical data. We aim at creating this data set for DNA patents related to diagnostic genetic testing. To this end we developed two tools to facilitate this process. First, we set up a search strategy to find the relevant patents. Second, we provide a claim classification template to assist the user in the assessment of the subject matter covered by the patent claims and in creating a comprehensive overview of the patent situation within this field. These tools have been used in a pilot study on 11 selected hereditary disorders. In addition, a detailed analysis of the familial breast and ovarian cancer genes patents retrieved by the developed search strategy and their claim classification, after meticulous reading of the documents, allowed us to better describe the problems which medical geneticists and researchers might face when dealing with the patented technology.
Asunto(s)
Algoritmos , ADN , Técnicas y Procedimientos Diagnósticos , Técnicas Genéticas , Patentes como Asunto , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/genética , Bases de Datos Factuales , Europa (Continente) , Femenino , Genes BRCA1 , Genes BRCA2 , Enfermedades Genéticas Congénitas/diagnóstico , Enfermedades Genéticas Congénitas/genética , Humanos , Neoplasias Ováricas/diagnóstico , Neoplasias Ováricas/genéticaRESUMEN
The trans-activation response (TAR) RNA stem-loop that occurs at the 5' end of HIV RNA transcripts is an important antiviral target and is the site of interaction of the HIV-1 Tat protein together with host cellular factors. Oligonucleotides and their analogues targeted to TAR are potential antiviral candidates. We have investigated a range of cell penetrating peptide (CPP) conjugates of a 16mer peptide nucleic acid (PNA) analogue targeted to the apical stem-loop of TAR and show that disulfide-linked PNA conjugates of two types of CPP (Transportan or a novel chimeric peptide R6-Penetratin) exhibit dose-dependent inhibition of Tat-dependent trans-activation in a HeLa cell assay when incubated for 24 h. Activity is reached within 6 h if the lysosomotropic reagent chloroquine is co-administered. Fluorescein-labelled stably-linked conjugates of Tat, Transportan or Transportan TP10 with PNA were inactive when delivered alone, but attained trans-activation inhibition in the presence of chloroquine. Confocal microscopy showed that such fluorescently labelled CPP-PNA conjugates were sequestered in endosomal or membrane-bound compartments of HeLa cells, which varied in appearance depending on the CPP type. Co-administration of chloroquine was seen in some cases to release fluorescence from such compartments into the nucleus, but with different patterns depending on the CPP. The results show that CPP-PNA conjugates of different types can inhibit Tat-dependent trans-activation in HeLa cells and have potential for development as antiviral agents. Endosomal or membrane release is a major factor limiting nuclear delivery and trans-activation inhibition.
Asunto(s)
Antivirales/química , Antivirales/farmacología , Productos del Gen tat/antagonistas & inhibidores , VIH-1/efectos de los fármacos , Ácidos Nucleicos de Péptidos/química , Ácidos Nucleicos de Péptidos/farmacología , Activación Transcripcional/efectos de los fármacos , Antivirales/análisis , Permeabilidad de la Membrana Celular , Cloroquina/farmacología , Fluoresceínas/química , Colorantes Fluorescentes/química , Duplicado del Terminal Largo de VIH , Células HeLa , Humanos , Membranas Intracelulares/química , Microscopía Confocal , Ácidos Nucleicos de Péptidos/análisis , Productos del Gen tat del Virus de la Inmunodeficiencia HumanaRESUMEN
Cellular uptake of a family of cationic cell-penetrating peptides (examples include Tat peptides and penetratin) have been ascribed in the literature to a mechanism that does not involve endocytosis. In this work we reevaluate the mechanisms of cellular uptake of Tat 48-60 and (Arg)(9). We demonstrate here that cell fixation, even in mild conditions, leads to the artifactual uptake of these peptides. Moreover, we show that flow cytometry analysis cannot be used validly to evaluate cellular uptake unless a step of trypsin digestion of the cell membrane-adsorbed peptide is included in the protocol. Fluorescence microscopy on live unfixed cells shows characteristic endosomal distribution of peptides. Flow cytometry analysis indicates that the kinetics of uptake are similar to the kinetics of endocytosis. Peptide uptake is inhibited by incubation at low temperature and cellular ATP pool depletion. Similar data were obtained for Tat-conjugated peptide nucleic acids. These data are consistent with the involvement of endocytosis in the cellular internalization of cell-penetrating peptides and their conjugates to peptide nucleic acids.
Asunto(s)
Endocitosis/fisiología , Productos del Gen tat/metabolismo , Péptidos/metabolismo , Fijación del Tejido , Adenosina Trifosfato/metabolismo , Animales , Línea Celular , Fijadores/metabolismo , Citometría de Flujo , Colorantes Fluorescentes/metabolismo , Productos del Gen tat/genética , Humanos , Microscopía Fluorescente , Péptidos/genética , Tripsina/metabolismoRESUMEN
The syntheses of monomeric nucleosides and 3'-O-phosphoramidite building blocks en route to alpha-L-ribo-configured locked nucleic acids (alpha-L-LNA), composed entirely of alpha-L-LNA monomers (alpha-L-ribo configuration) or of a mixture of alpha-L-LNA and DNA monomers (beta-D-ribo configuration), are described and the alpha-L-LNA oligomers are studied. Bicyclic 5-methylcytosin-1-yl and adenine-9-yl nucleoside derivatives have been prepared and the phosphoramidite approach has been used for the automated oligomerization leading to alpha-L-LNA oligomers. Binding studies revealed very efficient recognition of single-stranded DNA and RNA target oligonucleotide strands. Thus, stereoirregular alpha-L-LNA 11-mers containing a mixture of alpha-L-LNA monomers and DNA monomers ("mix-mer alpha-L-LNA") were shown to display DeltaT(m) values of +1 to +3 degrees C per modification toward DNA and +4 to +5 degrees C toward RNA when compared with the corresponding unmodified DNA x DNA and DNA x RNA reference duplexes. The corresponding DeltaT(m) values per modification for the stereoregular fully modified alpha-L-LNA were determined to be +4 degrees C (against DNA) and +5 degrees C (against RNA). 11-Mer alpha-L-LNAs (mix-mer alpha- L-LNA or fully modified alpha- L-LNA) were shown in vitro to be significantly stabilized toward 3'-exonucleolytic degradation. A duplex formed between RNA and either mix-mer alpha-L-LNA or fully modified alpha-L-LNA induced in vitro Escherichia coli RNase H-mediated cleavage, albeit very slow, of the RNA targets at high enzyme concentrations.
Asunto(s)
Ácidos Nucleicos/química , Nucleósidos de Purina/síntesis química , Nucleósidos de Pirimidina/síntesis química , Dicroismo Circular , Escherichia coli/enzimología , Calor , Conformación Molecular , Ácidos Nucleicos/síntesis química , Compuestos Organofosforados/síntesis química , Compuestos Organofosforados/química , Fosfodiesterasa I , Hidrolasas Diéster Fosfóricas/química , Nucleósidos de Purina/química , Nucleósidos de Pirimidina/química , Ribonucleasa H/químicaRESUMEN
Ribonuclease mimics based on diimidazole derived constructs in combination with or without additional amino groups have been synthesized and conjugated to oligonucleotides. The imidazole moiety was used either unprotected, protected with a monomethoxytrityl group or a tert-butyloxy carbonyl group. Acylation reactions were carried out using the 3-acyl-1,3-thiazolidine-2-thione activation strategy. The peptides were coupled to the oligonucleotides with a mixture of PyBOP, DIEA an HOBt in DMF on solid support. The conjugates were purified by RP-HPLC and identified using negative ion mode mass spectrometry. Unfortunately, no cleavage of a linear RNA target under physiological conditions could be observed.